Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer
Titel:
Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer
Auteur:
Zhang, J. Lin, Y. Sun, X.J. Wang, B.Y. Wang, Z.H. Luo, J.F. Wang, L.P. Zhang, S. Cao, J. Tao, Z.H. Wu, J. Shao, Z.M. Yang, W.T. Hu, X.C.